| 标题 |
An imprecise label in the era of precision medicine: labelling and access for daraxonrasib, the first pan-RAS inhibitor approval |
| 网址 | |
| DOI | |
| 其它 |
期刊:Nature Reviews Clinical Oncology 作者:Vivek Subbiah; Razelle Kurzrock 出版日期:2026-10-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)